Albert complainedor tried to
Personal or family history of medullary thyroid cancer or multiple endocrine neoplasia (MEN) type 2 Please note that these eligibility criteria are not exhaustive, and it is crucial to consult with your healthcare provider for a comprehensive assessment of your individual circumstances
has been on the advisory panel of, a consultant for, in the speaker's bureau of, owns shares in, and/or has received research support from 89bio, AstraZeneca, Boehringer Ingelheim, Cytoki Pharma, Eli Lilly, Gubra, Novo Nordisk, Merck Sharp & Dohme, Sanofi, Structure Therapeutics, Zealand Pharma, and Zucara
If additional glycemic control is needed, the dose may be increased to 1 mg weekly after at least four weeks, and potentially to a maximum of 2 mg weekly